Literature DB >> 15236414

POMGnT1 gene alterations in a family with neurological abnormalities.

Virginie S Vervoort1, Kenton R Holden, Kennedy C Ukadike, Julianne S Collins, Robert A Saul, Anand K Srivastava.   

Abstract

Muscle-eye-brain disease (MEB), is caused by mutations in the POMGnT1 gene. We describe a white family with two siblings affected with congenital hypotonia early-onset glaucoma, and psychomotor delays. Brain magnetic resonance images (MRIs) showed hydrocephalus, bilateral frontal polymicrogyria, abnormal cerebellum, and characteristic flattened dystrophic pons. We identified novel POMGnT1 gene alterations in this family. Both affected siblings were found to be compound hetrozygotes and carried two missense changes inherited from their mother and one missense change (p.R442C) inherited from their father. Our findings further define the phenotypic spectrum of MEB and its occurrence in the US population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15236414     DOI: 10.1002/ana.20172

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

Review 1.  The congenital muscular dystrophies: recent advances and molecular insights.

Authors:  Jerry R Mendell; Daniel R Boué; Paul T Martin
Journal:  Pediatr Dev Pathol       Date:  2006 Nov-Dec

2.  Golgi phosphoprotein 3 mediates the Golgi localization and function of protein O-linked mannose β-1,2-N-acetlyglucosaminyltransferase 1.

Authors:  Natasha A Pereira; Helen X Pu; Hazel Goh; Zhiwei Song
Journal:  J Biol Chem       Date:  2014-04-14       Impact factor: 5.157

3.  Muscle-Eye-Brain disease.

Authors:  Anant M Shenoy; Jennifer A Markowitz; Carsten G Bonnemann; Kalpathy Krishnamoorthy; Aaron D Bossler; Brian S Tseng
Journal:  J Clin Neuromuscul Dis       Date:  2010-03

4.  Novel POMGnT1 mutations define broader phenotypic spectrum of muscle-eye-brain disease.

Authors:  Ute Hehr; Goekhan Uyanik; Claudia Gross; Maggie C Walter; Axel Bohring; Monika Cohen; Barbara Oehl-Jaschkowitz; Lynne M Bird; Ghiat M Shamdeen; Ulrich Bogdahn; Gerhard Schuierer; Haluk Topaloglu; Ludwig Aigner; Hanns Lochmüller; Jürgen Winkler
Journal:  Neurogenetics       Date:  2007-09-29       Impact factor: 2.660

5.  Novel POMGNT1 point mutations and intragenic rearrangements associated with muscle-eye-brain disease.

Authors:  S Saredi; A Ardissone; A Ruggieri; E Mottarelli; L Farina; R Rinaldi; E Silvestri; C Gandioli; S D'Arrigo; F Salerno; L Morandi; P Grammatico; C Pantaleoni; I Moroni; M Mora
Journal:  J Neurol Sci       Date:  2012-05-02       Impact factor: 3.181

6.  Biochemical correlation of activity of the α-dystroglycan-modifying glycosyltransferase POMGnT1 with mutations in muscle-eye-brain disease.

Authors:  Josef Voglmeir; Sara Kaloo; Nicolas Laurent; Marco M Meloni; Lisa Bohlmann; Iain B H Wilson; Sabine L Flitsch
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

7.  Evolution of protein N-glycosylation process in Golgi apparatus which shapes diversity of protein N-glycan structures in plants, animals and fungi.

Authors:  Peng Wang; Hong Wang; Jiangtao Gai; Xiaoli Tian; Xiaoxiao Zhang; Yongzhi Lv; Yi Jian
Journal:  Sci Rep       Date:  2017-01-11       Impact factor: 4.379

8.  Novel copy number variation of POMGNT1 associated with muscle-eye-brain disease detected by next-generation sequencing.

Authors:  Xiaona Fu; Haipo Yang; Hui Jiao; Shuo Wang; Aijie Liu; Xiaoqing Li; Jiangxi Xiao; Yanling Yang; Xiru Wu; Hui Xiong
Journal:  Sci Rep       Date:  2017-08-01       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.